Centessa Pharmaceuticals plc (LON:0ACX)
24.27
+0.47 (1.97%)
At close: Oct 24, 2025
Centessa Pharmaceuticals Revenue
Centessa Pharmaceuticals had revenue of $15.00M USD in the twelve months ending June 30, 2025, up 118.88% year-over-year.
Revenue (ttm)
$15.00M
Revenue Growth
+118.88%
P/S Ratio
222.28
Revenue / Employee
$194.81K
Employees
77
Market Cap
2.43B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.85M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |
Centessa Pharmaceuticals News
- 18 days ago - Guggenheim Reiterates Buy Rating on Centessa Pharmaceuticals (CNTA) | CNTA Stock News - GuruFocus
- 5 weeks ago - Insider Sell: Mario Accardi Sells 8,172 Shares of Centessa Pharmaceuticals PLC - GuruFocus
- 6 weeks ago - Centessa (CNTA) Stock Surges Over 15% in Recent Trading - GuruFocus
- 7 weeks ago - Centessa Pharmaceuticals (CNTA): Wells Fargo Initiates Coverage with Overweight Rating | CNTA ... - GuruFocus
- 7 weeks ago - Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare ... - GuruFocus
- 7 weeks ago - Centessa Pharmaceuticals PLC to Participate in Morgan Stanley Global Healthcare Conference | ... - GuruFocus
- 7 weeks ago - Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Centessa Pharmaceuticals GAAP EPS of -$0.38 misses by $0.04 - Seeking Alpha